TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES
申请人:AGOURON PHARMACEUTICALS, INC.
公开号:EP1208104A2
公开(公告)日:2002-05-29
US6548494B1
申请人:——
公开号:US6548494B1
公开(公告)日:2003-04-15
[EN] TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES<br/>[FR] INHIBITEURS TRICYCLIQUES DE POLY(ADP-RIBOSE) POLYMERASES
申请人:AGOURON PHARMA
公开号:WO2001016136A2
公开(公告)日:2001-03-08
Compounds of the formula (I) are poly(ADP-ribosyl)transferase inhibitors. Such compounds are useful as therapeutics in treating cancers and in ameliorating the effects of stroke, head trauma, and neurodegenerative disease.
Tricyclic inhibitors of poly(ADP-ribose) polymerases
申请人:Agouron Pharmaceuticals, Inc.
公开号:US06548494B1
公开(公告)日:2003-04-15
Compounds of the formula shown below are poly(ADP-ribosyl)transferase inhibitors:
Such compounds are useful as therapeutics in treating cancers and in ameliorating the effects of stroke, head trauma, and neurodegenerative disease.